名稱 | AI-Edigene® EML4(E18)-ALK(E20) V2 Fusion |
型號 | CBP20196R |
報價 | |
特點 | AI-Edigene® EML4(E18)-ALK(E20) V2 Fusion |
產品搜索
相關文章
聯(lián)系我們
聯(lián)系人:蔣經理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產品展示 / PRODUCTS
- 詳細內容
CBP20196R |
Format | RNA |
Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor activity in mouse models (PMID: 19064915, PMID: 17625570). EML4-ALK fusions have been associated with non-small cell lung cancer (PMID: 26755435). |
Technical Data | |
Left Gene | EML4 |
Left Breakpoint | chr2:42543844:+ |
Right Gene | ALK |
Right Breakpoint | chr2:29446566:- |
Cosmic ID | COSF488 |
Buffer | RNase-free H2O |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | -80℃ |
Expiry | 12 months from the date of manufacture |